CSPC Pharmaceutical Group (CSPC Pharmaceutical Group) 3-Year Book Growth Rate : 18.10% (As of Sep. 2023)

View and export this data going back to . Start your Free Trial

What is CSPC Pharmaceutical Group 3-Year Book Growth Rate?

CSPC Pharmaceutical Group's Book Value per Share for the quarter that ended in Sep. 2023 was $0.00.

During the past 12 months, CSPC Pharmaceutical Group's average Book Value per Share Growth Rate was 6.20% per year. During the past 3 years, the average Book Value per Share Growth Rate was 18.10% per year. During the past 5 years, the average Book Value per Share Growth Rate was 19.20% per year. During the past 10 years, the average Book Value per Share Growth Rate was 14.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of CSPC Pharmaceutical Group was 54.40% per year. The lowest was -41.70% per year. And the median was 20.50% per year.

Competitive Comparison of CSPC Pharmaceutical Group's 3-Year Book Growth Rate

For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CSPC Pharmaceutical Group's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where CSPC Pharmaceutical Group's 3-Year Book Growth Rate falls into.

CSPC Pharmaceutical Group 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

CSPC Pharmaceutical Group (OTCPK:CHJTF) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

CSPC Pharmaceutical Group 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

CSPC Pharmaceutical Group (CSPC Pharmaceutical Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (OTCPK:CHJTF) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

CSPCY:USA 01093:Hong Kong CVG:Germany

Address

No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035

Website

https://www.cspc.com.hk

CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.

CSPC Pharmaceutical Group (CSPC Pharmaceutical Group) Headlines

From GuruFocus

Value Partners Classic Fund Comments on CSPC Pharmaceutical

By Vera Yuan Vera Yuan • 07-29-2014